Response Oncology (Response Oncology) Price-to-Free-Cash-Flow : 0.00 (As of Apr. 25, 2024)

Response Oncology Price-to-Free-Cash-Flow Chart

Response Oncology Annual Data
	Trend	Dec92	Dec93	Dec94	Dec95	Dec96	Dec97	Dec98	Dec99	Dec00	Dec01
Price-to-Free-Cash-Flow		Get a 7-Day Free Trial					17.46	44.13	1.13	0.68	0.08

Response Oncology Quarterly Data
	Jun97	Sep97	Dec97	Mar98	Jun98	Sep98	Dec98	Mar99	Jun99	Sep99	Dec99	Mar00	Jun00	Sep00	Dec00	Mar01	Jun01	Sep01	Dec01	Mar02
Price-to-Free-Cash-Flow	Get a 7-Day Free Trial															0.05	0.07	0.13	-	-

Competitive Comparison of Response Oncology's Price-to-Free-Cash-Flow

For the Medical Care Facilities subindustry, Response Oncology's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Response Oncology's Price-to-Free-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Response Oncology's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Response Oncology's Price-to-Free-Cash-Flow falls into.

Response Oncology Price-to-Free-Cash-Flow Calculation

Response Oncology's Price-to-Free-Cash-Flow ratio for today is calculated as

Response Oncology's Share Price of today is $0.0001.
Response Oncology's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2002 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.63.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Response Oncology  (GREY:ROIX) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

Response Oncology Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Response Oncology's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Response Oncology (Response Oncology) Business Description